How Rising Genetic Disorder Prevalence and Personalized Medicine Adoption Are Driving the Global Targeted Sequencing And Resequencing Market
The global Targeted Sequencing And Resequencing market is expanding as pharmaceutical companies, research institutions, and clinical laboratories invest in advanced genomic technologies to support drug discovery, biomarker research, and diagnostic applications. The market was valued at USD 4.93 billion in 2023 and is projected to reach USD 15.1 billion by 2032, growing at a CAGR of 13.24%. The...
0 Commentarii 0 Distribuiri 90 Views 0 previzualizare